版本:
中国

BRIEF-Novartis updates analyses from Kisqali pivotal late-stage trial

May 18 Novartis Ag-

* Novartis -data at ASCO, ICML and EHA meetings demonstrate meaningful advancements in cancer care- updated analyses from Kisqali pivotal phase iii monaleesa-2 trial Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐